Guggenheim kicked off coverage of Cigna with a Buy rating and a $384 target, praising its nimble healthcare strategy and reliable financial footing. The firm lauded Cigna’s flexible approach and low ...

The U.S. Federal Trade Commission’s lawsuit against major pharmacy benefit managers, including UnitedHealth Group’s Optum, ...

Federal Trade Commission Chair Andrew Ferguson has reversed course on his decision to recuse himself from the agency's legal ...

The health sector is experiencing significant disruptions, with the FTC halting a lawsuit against pharmacy-benefit managers ...

The FTC chair had previously been recused from the lawsuit. But after consulting with ethics lawyers, Ferguson changed his ...

FTC Chair Andrew Ferguson is no longer recusing himself from the matter, he said two days after a leadership shakeup at the ...

The FTC has paused its antitrust case against major PBMs, citing a lack of commissioners. The lawsuit alleges unfair practices that inflated insulin prices.

The FTC says it doesn’t have enough active commissioners to move forward after President Donald Trump fired two Democrats last month.

The ban was part of a settlement for a lawsuit by the Federal Trade Commission, which also required Rennick and two businesses tied to him to pay a combined $8 million. Despite that agreement ...

This week, the Federal Trade Commission halted its lawsuit against pharmacy-benefit managers CVS Caremark (CVS), Express Scripts (CI), and ...

Lauren Feiner is a senior policy reporter at The Verge, covering the intersection of Silicon Valley and Capitol Hill. She spent 5 years covering tech policy at CNBC, writing about antitrust ...